GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **226 - 250** of **4050** in total

« First

‹ Prev

…

6

7

8

9

10

11

12

13

14

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgG	Patient 2	3	mild	G94435QH	66
IgM	Patient 2	24	mild	G94435QH	68
IgM	Patient 2	3	mild	G94435QH	47
IgA	Patient 3	-180	mild	G94435QH	289
IgA	Patient 3	11	mild	G94435QH	392
IgG	Patient 3	-180	mild	G94435QH	50
IgM	Patient 3	-180	mild	G94435QH	100
IgA	Patient 3	4	mild	G94435QH	465
IgG	Patient 3	11	mild	G94435QH	51
IgG	Patient 3	4	mild	G94435QH	118
IgM	Patient 3	11	mild	G94435QH	167
IgM	Patient 3	4	mild	G94435QH	267
IgA	Patient 4	12	mild	G94435QH	456
IgG	Patient 4	12	mild	G94435QH	97
IgM	Patient 4	12	mild	G94435QH	439
IgA	Patient 1	10	moderate	G93351GM	415
IgA	Patient 1	22	moderate	G93351GM	393
IgA	Patient 1	6	moderate	G93351GM	357
IgG	Patient 1	10	moderate	G93351GM	35
IgG	Patient 1	22	moderate	G93351GM	40
IgM	Patient 1	10	moderate	G93351GM	50
IgM	Patient 1	22	moderate	G93351GM	115
IgG	Patient 1	6	moderate	G93351GM	32
IgM	Patient 1	6	moderate	G93351GM	45
IgA	Patient 2	15	mild	G93351GM	580